{"id":8645,"date":"2021-10-06T14:45:25","date_gmt":"2021-10-06T14:45:25","guid":{"rendered":"http:\/\/cvx.vc\/?p=8645"},"modified":"2021-10-06T14:45:25","modified_gmt":"2021-10-06T14:45:25","slug":"dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/","title":{"rendered":"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen"},"content":{"rendered":"<p>Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. V\u00e6kstkometen har allerede investorer som Eir Ventures og V\u00e6kstfonden i spidsen for den nye investeringsrunde, men ogs\u00e5 andre erhvervsprofiler indtr\u00e6der i ejerkredsen.<\/p>\n<p>Synklino er i gang med at udvikle et l\u00e6gemiddel, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationer. Pengene fra den nye investeringsrunde skal finansiere produktionen, afslutning af pr\u00e6kliniske studier og andre fors\u00f8g f\u00f8r den fremtidige b\u00f8rsnotering.<\/p>\n<p><em>&#8220;Vi er meget glade for igen at kunne tiltr\u00e6kke personer af h\u00f8j kaliber, som har den unikke ekspertise til at st\u00f8tte Synklino p\u00e5 sin meget ambiti\u00f8se rejse, hvilket i sidste ende giver patienterne en chance for at leve et normalt liv efter transplantationen,\u201d<\/em> udtaler Thomas Kledal, medstifter og CEO hos Synklino, i en pressemeddelelse.<\/p>\n<p>V\u00e6kstvirksomheden blev stiftet i 2017 af Thomas Kledal, Mette Rosenkilde og Mads G. Jeppesen, og den besk\u00e6ftiger i dag 13 medarbejdere. Den eksisterende ejerkreds best\u00e5r bl.a. af North Finance og en r\u00e6kke business angels, som ligeledes deltager i den nye investeringsrunde.<\/p>\n<p>L\u00e6s hele artiklen p\u00e5 KapWatch <a href=\"https:\/\/kapwatch.dk\/nyheder\/venturefonde\/article13336982.ece\"><em><strong>her<\/strong><\/em><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.<\/p>\n","protected":false},"author":25,"featured_media":8646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen | CVX Ventures<\/title>\n<meta name=\"description\" content=\"Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen\" \/>\n<meta property=\"og:description\" content=\"Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-06T14:45:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen\",\"datePublished\":\"2021-10-06T14:45:25+00:00\",\"dateModified\":\"2021-10-06T14:45:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\"},\"wordCount\":206,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\",\"name\":\"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg\",\"datePublished\":\"2021-10-06T14:45:25+00:00\",\"dateModified\":\"2021-10-06T14:45:25+00:00\",\"description\":\"Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen | CVX Ventures","description":"Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/","og_locale":"da_DK","og_type":"article","og_title":"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen","og_description":"Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.","og_url":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2021-10-06T14:45:25+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg","type":"image\/jpeg"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen","datePublished":"2021-10-06T14:45:25+00:00","dateModified":"2021-10-06T14:45:25+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/"},"wordCount":206,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/","url":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/","name":"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg","datePublished":"2021-10-06T14:45:25+00:00","dateModified":"2021-10-06T14:45:25+00:00","description":"Den danske v\u00e6kstvirksomhed Synklino vil rejse 35 mio. kr. i en pre-IPO runde. Synklino vil udvikle l\u00e6gemidler, der kan helbrede transplantationspatienter, som lider af kroniske virusinfektioner efter operationen.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/10\/Synklino.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotech-komet-gor-klar-til-ipo-vil-rejse-tocifret-millionbelob-inden-borsnoteringen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"Dansk BioTech-komet g\u00f8r klar til IPO: Vil rejse tocifret millionbel\u00f8b inden b\u00f8rsnoteringen"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/8645"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=8645"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/8645\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/8646"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=8645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=8645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=8645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}